Africa CDC institutional autonomy and the AU pivot

<p>The Africa Centres for Disease Control and Prevention (Africa CDC) was established by the African Union in 2017 as a Specialized Technical Institution of the AU Commission, headquartered in Addis Ababa, with an initial focus on surveillance, emergency response, and public-health capacity-building across the 55 AU member states. The 2022 reform — elevating Africa CDC from a Commission agency to an autonomous AU specialized agency with direct reporting to the AU Assembly — was the structural change that gives the institution its current operational independence.</p> <p>John Nkengasong (the founding director through 2021) led the institution through Ebola response (the 2018–2020 DRC outbreak), the COVID-19 pandemic response (2020–2022), and the institutional-architecture work that produced the autonomy reform. Jean Kaseya (director-general from 2023) inherited the post-COVID consolidation challenge: the substantial donor-funded infrastructure built during the pandemic needed to be transitioned to sustainable AU-budget-supported operations, the surveillance network needed to be maintained through the post-emergency funding cliff, and the partnerships with WHO Africa and with the regional economic communities&#x27; health pillars needed to be normalized.</p> <p>The institutional autonomy matters because Africa CDC&#x27;s effectiveness during COVID — particularly the AVATT vaccine-procurement programme that the African Union Special Envoy Strive Masiyiwa led during 2020–2021 — depended on the ability to negotiate directly with Pfizer, J&amp;J, AstraZeneca, and the Serum Institute as a continental purchaser, rather than as 55 separate national purchasers competing against each other and against the COVAX facility. The continental-purchasing capacity that the AVATT episode demonstrated is the institutional capacity that Africa CDC has been trying to consolidate for subsequent public-health goods (mpox vaccines, the more recent malaria-vaccine rollout, the antiretroviral procurement programmes).</p> <p>Nicaise Ndembi (Africa CDC chief scientist), Salim Abdool Karim at CAPRISA, and the broader African public-health research community have written extensively on the institution&#x27;s evolution. The 2022 *Lancet* commission on public-health architecture in Africa, the African Academy of Sciences&#x27; policy work, and the Bellagio Center 2023 convening on African public-health sovereignty have made the case for the continued institutional strengthening.</p> <p>The constraints are real. The AU&#x27;s regular-budget contribution to Africa CDC covers a small share of operational costs; the majority is donor-funded (Gates Foundation, Mastercard Foundation, EU, African Export-Import Bank, China). The post-COVID donor-funding pullback has produced budget pressure that the AU-member-state assessed contributions have not closed. The structural sustainability of Africa CDC depends on AU member states meeting their financial obligations to the institution at a rate that has historically been below the assessed level. The institution exists; whether it sustains its current operational footprint through the next major continental health emergency, without depending on emergency donor mobilization at the scale that COVID produced, is the underlying question.</p>